Sponsor this section
Loading...
You are here:  Home  >  Tri-County Economy  >  East Ventura County  >  Current Article

Amgen teams up with Merck on melanoma treatments

By   /   Thursday, February 6th, 2014  /   Comments Off

Thousand Oaks-based Amgen and pharmaceutical giant Merck are working together to evaluate the safety and effectiveness of combined treatments for melanoma patients.

    Print       Email

Thousand Oaks-based Amgen and pharmaceutical giant Merck are working together to evaluate the safety and effectiveness of combined treatments for melanoma patients, the companies announced Feb. 5.

The agreement, entered into through a subsidiary, will evaluate the use of the cancer-killing virus talimogene laherparepvec combined with MK-3475, an immunotherapy that targets PD-1, a protein on the surface of immune cells. The treatments are meant for patients with mid- to late-stage melanoma.

“We are pleased to be collaborating with Amgen to study MK-3475 as part of this novel combination regimen,” Dr. Eric Rubin, vice president of clinical development for oncology at Merck Research Laboratories, said in a statement. “Early evaluation of immunotherapeutic combinations is important in accelerating the development of new options for patients with cancer.” Merck, based in New Jersey, is known as MSD outside of the United States and Canada.

The open-label clinical trial will be conducted in two parts and is planned to begin this fall.

Melanoma is the most aggressive and serious form of skin cancer. While melanoma accounts for less than 5 percent of skin cancer cases in the United States, it causes the most skin cancer deaths.

    Print       Email
  • Sign up for email news

    Get the Business Times in your inbox. Sign up for breaking news alerts, our weekly briefing, and more.
    Sign up
  • The Latest Lists

    The Latest Lists

    Purchase the digital version of the 2014 Book of Lists or download Excel versions of our weekly Top 25 lists. [Click here]

  • 2013 Giving Guide

    2013 Giving Guide



    Read our free guide to nonprofits and philanthropy in the Tri-Counties

You might also like...

The eyes have it when it comes to Medicare payouts

Read More →